Marvell Technology (NASDAQ: MRVL) COO details RSU vesting and tax share surrender

Rhea-AI Filing Summary

Marvell Technology President and COO Christopher Koopmans, through the Christopher R. Koopmans and Heather J. Koopmans Family Trust, reported multiple restricted stock unit (RSU) vesting events and related share movements on January 15, 2026. RSU conversions added blocks of 4,497, 2,787, and 4,077 shares of common stock to the trust at an exercise price of $0 per share. In connection with these vestings, the trust surrendered 2,350, 1,382, and 2,022 shares of common stock at $80.38 per share to cover tax withholding obligations. Following these transactions, the family trust held 143,870 shares of Marvell common stock indirectly for Koopmans. The filing also notes that remaining RSUs are scheduled to vest in tranches from April 15, 2026 through April 15, 2028.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CA 95054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		M		4,497	A	$0	142,760	I	By Trust(1)
Common Stock	01/15/2026		F(2)		2,350	D	$80.38	140,410	I	By Trust(1)
Common Stock	01/15/2026		M		2,787	A	$0	143,197	I	By Trust(1)
Common Stock	01/15/2026		F(2)		1,382	D	$80.38	141,815	I	By Trust(1)
Common Stock	01/15/2026		M		4,077	A	$0	145,892	I	By Trust(1)
Common Stock	01/15/2026		F(2)		2,022	D	$80.38	143,870	I	By Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	01/15/2026		M			4,497	(4)	(4)	Common Stock	4,497	$0	4,498	D
Restricted Stock Units	(3)	01/15/2026		M			2,787	(5)	(5)	Common Stock	2,787	$0	13,938	D
Restricted Stock Units	(3)	01/15/2026		M			4,077	(6)	(6)	Common Stock	4,077	$0	36,693	D

Explanation of Responses:

1. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

2. Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock Units.

3. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.

4. The remaining Restricted Stock Units shall vest on April 15, 2026.

5. The remaining Restricted Stock Units shall vest on April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

6. The remaining Restricted Stock Units shall vest on April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028 and April 15, 2028.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Marvell (MRVL) report for Christopher Koopmans?

The filing shows Christopher Koopmans, Marvell's President and COO, reported RSU vesting on January 15, 2026, with new common shares issued to a family trust and some shares surrendered to cover tax withholding.

How many Marvell shares does the Koopmans Family Trust hold after the January 15, 2026 transactions?

After the reported transactions, the Christopher R. Koopmans and Heather J. Koopmans Family Trust held 143,870 shares of Marvell common stock indirectly for Koopmans.

What prices were used in the Marvell (MRVL) insider Form 4 transactions?

Common shares issued from RSU vesting were acquired at an exercise price of $0 per share, while shares surrendered for tax withholding were valued at $80.38 per share.

Were the Marvell (MRVL) insider transactions direct or through an entity?

The common stock transactions were reported as indirect ownership, with shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

What do the 'F' coded transactions mean in this Marvell insider filing?

Transactions coded "F" reflect the surrender of shares to pay tax withholding obligations arising from the vesting of restricted stock units, rather than open-market sales.

When will Christopher Koopmans' remaining Marvell RSUs vest?

Footnotes state that remaining RSUs are scheduled to vest in installments on dates including April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028 and April 15, 2028.